| Primary |
| Product Used For Unknown Indication |
42.4% |
| Benign Prostatic Hyperplasia |
16.8% |
| Prostatomegaly |
7.0% |
| Hypertension |
4.3% |
| Prostatic Disorder |
3.7% |
| Renal Transplant |
2.7% |
| Asthma |
2.4% |
| Diabetes Mellitus |
2.4% |
| Lower Urinary Tract Symptoms |
2.4% |
| Prophylaxis |
2.4% |
| Atrial Fibrillation |
2.1% |
| Cardiac Failure Chronic |
1.5% |
| Parkinson's Disease |
1.5% |
| Cardiac Failure |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Dysuria |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Urinary Retention |
1.2% |
| Urinary Tract Obstruction |
1.2% |
| Biopsy Prostate |
0.9% |
|
| Syncope |
13.4% |
| Testicular Swelling |
8.5% |
| Bradycardia |
6.1% |
| Oedema Peripheral |
6.1% |
| Vision Blurred |
6.1% |
| Erectile Dysfunction |
4.9% |
| Hypokalaemia |
4.9% |
| Liver Function Test Abnormal |
4.9% |
| Presyncope |
4.9% |
| Visual Acuity Reduced |
4.9% |
| Vomiting |
4.9% |
| Megakaryocytes Increased |
3.7% |
| Orthostatic Hypotension |
3.7% |
| Product Substitution Issue |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Therapeutic Response Unexpected |
3.7% |
| Urinary Retention |
3.7% |
| Visual Impairment |
3.7% |
| Dizziness |
2.4% |
| Feeling Abnormal |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
59.4% |
| Benign Prostatic Hyperplasia |
7.0% |
| Hypertension |
5.1% |
| Drug Use For Unknown Indication |
3.7% |
| Prostatomegaly |
3.1% |
| Bladder Disorder |
2.5% |
| Malignant Lymphoid Neoplasm |
2.5% |
| Completed Suicide |
2.3% |
| Coronary Artery Disease |
1.6% |
| Lower Urinary Tract Symptoms |
1.6% |
| Depression |
1.4% |
| Parkinson's Disease |
1.2% |
| Prophylaxis |
1.2% |
| Prostate Cancer |
1.2% |
| Urinary Hesitation |
1.2% |
| Atrial Fibrillation |
1.0% |
| Erectile Dysfunction |
1.0% |
| Nocturia |
1.0% |
| Renal Transplant |
1.0% |
| Mydriasis |
0.8% |
|
| Completed Suicide |
15.7% |
| Vascular Pain |
11.2% |
| Sexual Dysfunction |
10.1% |
| Syncope |
6.7% |
| Testicular Pain |
5.6% |
| Toxicity To Various Agents |
5.6% |
| Vomiting |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Blood Sodium Decreased |
3.4% |
| Death |
3.4% |
| Floppy Iris Syndrome |
3.4% |
| Hypotension |
3.4% |
| Rash Pustular |
3.4% |
| Tremor |
3.4% |
| Urinary Retention |
3.4% |
| Urinary Tract Infection |
3.4% |
| Acute Febrile Neutrophilic Dermatosis |
2.2% |
| Anaphylactic Reaction |
2.2% |
| Hyponatraemia |
2.2% |
| Intentional Drug Misuse |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
50.5% |
| Hypertension |
8.7% |
| Drug Use For Unknown Indication |
6.9% |
| Benign Prostatic Hyperplasia |
4.1% |
| Pain |
3.1% |
| Atrial Fibrillation |
2.8% |
| Diabetes Mellitus |
2.6% |
| Prophylaxis |
2.5% |
| Prostate Cancer |
2.5% |
| Blood Cholesterol Increased |
2.0% |
| Depression |
1.8% |
| Rheumatoid Arthritis |
1.6% |
| Prostatic Disorder |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Cardiac Disorder |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Colorectal Cancer Metastatic |
1.3% |
| Constipation |
1.3% |
| Back Pain |
1.2% |
| Multiple Myeloma |
1.1% |
|
| Death |
12.3% |
| Drug Ineffective |
8.7% |
| Weight Decreased |
8.2% |
| Vomiting |
7.7% |
| Pneumonia |
6.2% |
| Urinary Tract Infection |
5.7% |
| Sepsis |
5.1% |
| Weight Increased |
5.0% |
| Syncope |
4.5% |
| Thrombocytopenia |
3.9% |
| Nausea |
3.6% |
| Renal Failure Acute |
3.6% |
| Off Label Use |
3.4% |
| Renal Failure |
3.4% |
| Tremor |
3.4% |
| Urinary Retention |
3.4% |
| Dyspnoea |
3.1% |
| Pain |
3.1% |
| Renal Impairment |
2.9% |
| Diarrhoea |
2.7% |
|
| Interacting |
| Atrial Fibrillation |
10.5% |
| Hypertonic Bladder |
10.5% |
| Product Used For Unknown Indication |
10.5% |
| Prostatomegaly |
6.6% |
| Asthma |
5.3% |
| Benign Prostatic Hyperplasia |
5.3% |
| Diabetes Mellitus |
5.3% |
| Hypothyroidism |
5.3% |
| Pain |
5.3% |
| Urinary Tract Disorder |
5.3% |
| Hepatitis C |
3.9% |
| Hepatitis C Virus Test Positive |
3.9% |
| Hypertension |
3.9% |
| Affective Disorder |
2.6% |
| Cough |
2.6% |
| Diarrhoea |
2.6% |
| Erectile Dysfunction |
2.6% |
| Hypogonadism |
2.6% |
| Muscle Spasms |
2.6% |
| Nausea |
2.6% |
|
| Therapeutic Response Unexpected |
26.7% |
| Drug Ineffective |
13.3% |
| Drug Interaction |
13.3% |
| Presyncope |
13.3% |
| Priapism |
13.3% |
| Pancytopenia |
6.7% |
| Product Lot Number Issue |
6.7% |
| Sleep Disorder |
6.7% |
|
